HCWB — Hcw Biologics Cashflow Statement
0.000.00%
Last trade - 00:00- $8.57m
- $17.59m
- $2.57m
Annual cashflow statement for Hcw Biologics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.8 | -12.9 | -14.9 | -25 | -30 |
| Depreciation | |||||
| Non-Cash Items | 0.022 | -0.112 | 1.31 | 5.99 | 1.01 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.25 | 1.46 | 2.49 | -4.64 | 13.6 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -10.4 | -11 | -10.4 | -22.5 | -14.2 |
| Capital Expenditures | -0.187 | -0.047 | -10.3 | -6.2 | -0.262 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -35 | 25 | 10 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.187 | -35 | 14.7 | 3.8 | -0.262 |
| Financing Cash Flow Items | — | -6.76 | -0.191 | 0 | -0.638 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 11.7 | 49.3 | 6.27 | -0.015 | 15.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.1 | 3.27 | 10.6 | -18.7 | 1.08 |